Lupin launches generic version of Apriso
May 19, 2020 | Tuesday | News
It is indicated for the maintenance of remission of ulcerative colitis in patients 18 years of age and older
Source: Shutterstock
Lupin has announced the launch of authorized generic version of Bausch Health’s Apriso® (Mesalamine Extended-Release Capsules 0.375 g) in the U.S.
Mesalamine Extended-Release Capsules 0.375 g (authorized generic version) are indicated for the maintenance of remission of ulcerative colitis in patients 18 years of age and older.
Mesalamine Extended-Release Capsules 0.375 g, RLD: Apriso® had an annual sales of approximately USD 290 million in the U.S. (IQVIA MAT March 2020).
